Provided by Tiger Fintech (Singapore) Pte. Ltd.

Titan Pharmaceuticals

4.45
-0.0250-0.56%
Post-market: 4.450.00000.00%19:33 EDT
Volume:3.61K
Turnover:16.03K
Market Cap:4.07M
PE:-0.97
High:4.54
Open:4.54
Low:4.35
Close:4.48
Loading ...
Jan 24, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 03, 2022

Major Issues Report

8-K - Current report
Dec 29, 2021

Major Issues Report

8-K - Current report
Dec 22, 2021

Major Issues Report

8-K - Current report
Dec 14, 2021

Major Issues Report

8-K - Current report
Nov 15, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2021

Major Issues Report

8-K - Current report
Oct 28, 2021

Major Issues Report

8-K - Current report
Oct 26, 2021

Major Issues Report

8-K - Current report
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jul 26, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 31, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 04, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 04, 2021

Major Issues Report

8-K - Current report
Feb 04, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 27, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Jan 25, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 22, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 21, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals